EPISODE · Jun 24, 2026 · 21 MIN
915. 新型抗癌针剂可根除肿瘤：临床试验获突破
from 知为谁 · host 知为谁
《卫报》这篇报道介绍了新型抗癌注射药物 Amivantamab 在临床试验中取得的突破性进展。这种被称为“智能疫苗”的药物通过三重作用机制阻断肿瘤生长并激活免疫系统，成功使部分头颈癌和肺癌患者的病灶彻底消失。该疗法针对的是已对化疗和免疫疗法产生耐药性的难治性病例，且表现出极佳的临床效果。相比传统静脉注射，这种皮下注射方式显著缩短了治疗时间并减少了副作用，改善了患者的生活质量。专家认为，这一研究成果为缺乏治疗选择的晚期癌症群体带来了全新的生存希望。此次试验的详细数据已在全球最重要的癌症学术会议上正式发布。内容来源：https://www.theguardian.com/science/2026/may/30/cancer-jab-can-eradicate-entire-tumours-in-patients-trial-shows
Embed this episode
Ready to play
915. 新型抗癌针剂可根除肿瘤：临床试验获突破
0:00
21:19
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of 知为谁?
This episode is 21 minutes long.
When was this 知为谁 episode published?
This episode was published on June 24, 2026.
Can I download this 知为谁 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!